Heparin binding to serum proteins and their subsequent precip itation is reportedly increased in cystic fibrosis (CF). We have confirmed this finding for CF patients over the age of 12 i11.34 + 2.42 mg/ml precipitated protein for normals ( n = 19) versus 17.46 5 4.60 mg/ml for CF patients ( n = 37), P < 0.001; 0.629 f 0.098 mg/ml precipitated heparin for normals versus 0.789 + 0.206 for CF patients, P < 0.01j. We have also shown that patients with a variety of pulmonary diseases unrelated to CF do not show this effect. When the amounts of protein and heparin precipitated are compared with the amount of IgG found in the whole serum sample, the correlation coefficients (protein r = 0.77; heparin, 0.74; n = 81) are significant at a level of P < 0.001. In addition, the report that young CF patients exhibit hypogammaglobulinemia prompted us to examine serum samples from CF patients and agematched controls under the age of 12. No differences were found.
These findings prompted us to identify the proteins precipitated from CF and control sera by heparin at pH 5.57. The literature provides little information, inasmuch as most serum protein-heparin interactions have been studied at neutral or basic pHs.
Because of its polyanionic character, we anticipated that heparin would interact most strongly with positively charged serum proteins, i.e., the gamma globulins. IgG, which represents the bulk of this class of proteins, is elevated in serum samples from many patients with cystic fibrosis (12, 13, 18, 21) . Matthews et al. (12) and Weeke et al. (21) both report that this elevation of serum IgG is correlated with severity of disease.
The results of this study show that IgG is indeed the major protein precipitated by heparin at pH 5.57 and suggest that precipitation of increased amounts of IgG is largely responsible for previous observations of heparin interactions with CF serum components.
To investigate the molecuiar basis for this effect, sera from patients with CF and from age-matched controls were precipitated MATERIALS AND METHODS with 50 mg% heparin at pH 5.57. Pellets resolubilized in 8 M urea were fractionated on DEAE-Sephadex and analyzed by doubleNOnfasting were to immunodiffusion, SDS-PAGE, immunoelectrophoresis, and radial clot at 4OC. Following centrifugation, the serum was removed, immunodiffusion. IgG constituted 55-56% of the eluted protein. aliquoted into plastic tubes (Falcon 2054), and stored for varying When serum from all donors was fractionated by Staph A-Seph-periods at -70°C. Samples were obtained with informed consent. arose into IgG and non-IgG fractions, 85-89% of heparin precipi-The protocol was approved by the Human Experimentation Comtable protein was in the IgG fraction. mittee of University Hospitals. Subjects. The patients in this study were diagnosed as having C F by clinical criteria and elevated sweat chloride concentrations. Speculation Severity of disease was graded using the clinical scoring method We conclude from this study that the major heparin-precipitable outlined by Doershuk, et (3) . For this study, patients with protein in human serum at pH 5.57 is l g~. The increased amounts scores over 75 are considered to have mild disease; 75-50, modof protein precipitated from serum of older patients with cystic erate disease; and less than 50, severe disease. The control popufibrosis merely reflects the elevated levels of in their serum. lation consisted of normal healthy volunteers and of patients with These findings do not support the hypothesis of pearson and ~~b i~ non-CF related pulmonary diseases. A detailed description of the (16) that a generalized defect in protein glycosylation is the basis subjects used in each study is provided in the appropriate sections. of the heparin effect, although a specific alteration of oligoMaterials. Porcine heparin (Grade I) and Staph A-Sepharose saccharides is not ruled out. In addition, this study of the heparin were obtained from Sigma Chemicals. IgG Quantiplate kits were does not provide any evidence that there is an alteration in obtained from Kallestad and DEAE-Sephadex from Pharmacia. glycoprotein:glycosaminoglycan interaction in cystic fibrosis.
Prepoured immunoelectrophoresis plates were obtained from Malay. Spectropor dialysis tubing (molecular weight cutoff: 6000-8000) was used throughout. Reagents for polyacrylamide electroCystic fibrosis (CF) is the most common genetic disorder among phoresis were supplied by Eastman. Caucasians in the United States, with an estimated incidence of Quantitation of protein and heparin. The amount of heparin one in every 2000 live births. It is widely accepted that CF is precipitated was quantitated indirectly by measuring the amount inherited as an autosomal recessive trait, and thus a defect in a of uronic acid in the pellet. The carbazole method, as modified by single protein is to be expected.
Bitter and Muir (1) and using glucuronic acid as standard, was Pearson and Lubin (15) have reported that precipitates formed employed. The % of uronic acid (weight for weight) in the heparin by addition of heparin at pH 5.57 to CF sera have higher protein used was also determined (3 1-33%). Since heparin is an alternating and heparin contents than precipitates formed in control sera. In copolymer of glucosamine and glucuronic acid, the amount of addition, they reported that serum proteins from patients with heparin in the precipitate could be calculated. cystic fibrosis had increased heparin-precipitating capacity. In a Protein was determined by the method of Lowry et al. (10) later paper (16), the same authors confirmed these findings and except when assaying the DEAE-Sephadex column fractions. In reported altered carbohydrate composition for glycoproteins prethis case, the fluorescamine assay of Udenfriend et al. (20) was cipitated from CF serum.
used because of its greater sensitivity. Bovine serum albumin was used as standard, except for the Staph A experiment where bovine IgG was used because this was the class of protein being studied. Heparin precipitation of serum protein. The method of Pearson and Lubin (15) was employed for the precipitation of serum proteins with heparin at pH 5.57. Briefly, I ml of serum was added to 30 ml of 50 mM ammonium acetate buffer, pH 5.5 containing 0.5 mg of porcine heparin per ml (the final pH of this solution was pH 5.57). The resulting precipitate was collected by centrifugation, washed with ammonium acetate buffer, and lyophilized. The pellet was resuspended in I ml of 0.5 M sodium bicarbonate in 10% ethanol and after 1 h incubation, 0.2 ml of 3N NaOH was added and the incubation was continued for 30 min.. until the pellet was completely solubilized.
Analysis of unprec$itated serumproteins. In order to analyze the unprecipitated serum components, the supernatants were decanted from the protein-heparin precipitates and dialyzed against 5% BaC12 to remove the unbound heparin (2) . The heparin-barium complex was removed by centrifugation (8000 rpm, 4OC, 30 min.) and the supernatant was then dialyzed extensively against glass distilled water, lyophilized, and resuspended in 50 mM barbital buffer, pH 8.0. This preparation is referred to as the supernatant.
DEA E-Sephadex chromatography. Heparin was separated from the precipitated proteins by DEAE-Sephadex chromatography. This procedure also results in the fractionation of these proteins. The protein-heparin precipitate from 1.5 ml of serum was dissolved in 3 ml of 50 mM Tris-HC1, (pH 8.0) containing 8 M urea and applied to a 1.0 by 13 cm DEAE-Sephadex (A-50) column that had been equilibrated with the sample buffer. After the column had been washed with 15 ml of buffer, it was eluted with a 100 ml NaCl gradient (0-1.0 M). Fractions of 1.15 ml were collected at a flow rate of 0.47 ml/min.
The protein content of the column fractions was monitored by following the absorbance at 280 nm. The proteins eluted as two peaks, which were dialyzed extensively against glass distilled water, lyophilized, and then resuspended in a volume of barbital buffer equivalent to that of the original serum sample. The ionic strength of the fractions was monitored by a Radiometer-Copenhagen conductivity meter, type CDM3.
Immunoanalytical methods. Immunoelectrophoresis of column fractions was performed with 50 mM barbital buffer, pH 8.0. A constant current of 25 mA per plate was applied and the voltage never exceeded 300 mV. "Hoat" antihuman serum antiserum (Kallestad) was used in this system. IgG was quantitated by radial immunodiffusion. Double immunodiffusion analysis was carried out by the method of Ouchterlony and Nilson (14) .
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). SDS, 10% polyacrylamide slab gels were used according to the method of Laemmli and Favre (7) . Samples in 5% 2-mercaptoethanol and 0.5% SDS were electrophoresed for approximately 3 h at 4OC at a current of 35 mA per gel. Proteins were visualized using Commassie Blue R-250 stain.
Preparation of IgG and non-IgG serum fractions. Staph Protein A covalently coupled to Sepharose 4B was equilibrated in 0.1 M phosphate buffer, pH 7.0 at 4OC. Columns containing 1 ml of settled gel were poured and washed extensively with the starting buffer. Serum samples were centrifuged at 3000 rpm for 10 min to remove particulate matter and a 0.5 ml aliquot applied to each column. The columns were then washed with 30 ml of phosphate buffer, at which point the eluant no longer absorbed at 280 nm. The IgG fraction was then eluted with 6 ml of 1 M acetic acid. Both fractions were immediately dialyzed against glass distilled water and lyophilized. The fractions were resuspended in a volume of phosphate buffer equivalent to the original serum sample volume, heparin precipitated, and analyzed for protein and heparin.
Data analysis. Students t test for unpaired samples was used to determine the significance of difference between two means; 0.05 (two-tailed analysis) was used as the level of significance.
RESULTS
Analysis of serum protein-heparin precipitates. Table 1 data show that significantly more protein and heparin were precipitated from serum samples of C F subjects over the age of 12 than from agematched normal serum samples. Additionally, the protein/heparin combining ratio ie., mg of protein precipitated per mg of heparin precipitated, was significantly higher ( P < 0.01) in patients with CF (22.71 f 5.87) when compared with normal controls (18.3 -t 3.46). The concentration of IgG in C F sera was higher than in control sera.
Data from the two control groups were analyzed separately. No significant differences were found (Table 2) . Thus both groups were designated as the control population for this study. Table 3 presents an analysis of the data from older patients with C F according to the severity of their disease. All parameters showed significant differences when compared with the control group except the amount of heparin precipitated by serum and the IgG levels in serum of patients with mild disease.
When serum samples were studied from C F donors who were younger than age 12 and who had mild disease, no significant differences from age-matched control values were found (Table  4) .
In no case was the concentration of total protein in serum significantly different between C F and control donors.
Characterization of precipitated serum proteins. Precipitated proteins from serum samples from ten normal individuals and nine individuals with cystic fibrosis were solubilized as described and qualitatively analyzed by immunoelectrophoresis. immunodiffusion, and SDS-PAGE. Precipitated proteins from all 19 individuals consistently eluted as two peaks. The first peak contained proteins that did not bind to the ion exchanger and was designated Peak I; the bound proteins, which were released between 5 and 25 mS, were designated Peak 2. No carbazole reacting material was found in either peak.
Immunoelectrophoresis of whole serum, Peak I (DEAE-Sephadex) proteins solubilized from heparin precipitate, and supernatants resulted in the migration patterns shown in Figure l . The most electronegative gamma globulins were strikingly absent in the supernatant fraction, but were recovered in the precipitate fraction, Peak I. When the Peak 2 precipitate fractions were electrophoresed, most of the precipitin bands were found in the gamma globulin region, with occasional weak bands in the beta region (results not shown). This pattern was consistent for the 5 C F and 5 control serum samples examined, although the bands seen with normal sera were usually weaker than those from patients with cystic fibrosis. Double diffusion analysis of Peaks I and 2 from serum samples of six patients and six controls revealed the presence of IgG in both peaks. N o IgM, IgA, or lysozyme were detected. although these proteins were found in the supernatant fraction. The C3 component of complement was found in the supernatant and in both DEAE-Sephadex column fractions.
Column fractions from six normal individuals and six patients with C F were examined by SDS-PAGE and no qualitative differences between the two groups were found. Two protein bands that comigrated with IgG heavy and light chains were consistently found in both DEAE-Sephadex peaks of urea-solubilized precipitates. Other less prominent, but higher molecular weight protein bands appeared in Peak 2 fractions from control and CF sera. These have not been identified. Figure 2 shows a typical gel with samples from DEAE-Sephadex Peaks I and 2, supernatants. and whole serum from a normal donor and a C F donor.
Protein and immunoglobulin concentrations in DEAE-Sephadex fractions of solubilized precipitates were measured to determine if there were qualitative differences with respect to total protein and/or IgG content ( Table 5 ). The total amount of protein eluting from the DEAE-Sephadex column was significantly higher for serum samples from patients with cystic fibrosis. The amount of IgG in Peak 2 was three times higher for donors with cystic fibrosis; however, because of the wide variation among individ- ' Per ml of serum.
Protein was determined by the method of Lowry, er ol. (10) using bovine IgG as standard.
P < 0.001, and for precipitated heparin and IgG the correlation coefficient is 0.74, n = 81, P < 0.001. When the correlation coefficient is computed only for older cystic fibrosis patients, the results are very similar and are still significant at a ievel of P <
9 '
A om,. uals, these data are not statistically significant. It should also be noted that the ratio of IgG to total protein in each fraction was identical for the two groups.
Serum fractionation. In order to confirm that IgG is the major heparin-irecipitable protein, serum samples fro; 10 normal and 12 CF individuals were fractionated into non-IeG (Fraction A) and IgG (Fraction B) fractions by using Staph Kotiin ~-~e~h a : rose 4B to bind immunoglobulins of all subclasses except IgG3, which represents only about 5% of the total (15) . The two resulting fractions were heparin precipitated and the pellets were analyzed for protein and heparin.
As can be seen from Table 6 , approximately 80-85% of the precipitable protein in serum is contributed by Fraction B, which contains predominately IgG. Indeed, in some cases, virtually no precipitated protein could be detected in Fraction A.
Direct correlation of serum IgG concentrations with protein precipitation. Figure 3 shows the relationship between the amount of precipitated protein and the levels of IgG in whole serum from all donors. The correlation coeflicient for the amount of precipitated protein and the levels of IgG in the serum samples is 0.77, n = 8 1,
DISCUSSION
This study was initiated to re-examine the work of Pearson and Lubin (15, 16) who reported that heparin-protein precipitates from sera of cystic fibrosis patients contain both more heparin and more protein than precipitates from control sera. Our findings confirm these results with several exceptions. The amount of protein precipitated was significantly higher for serum samples from older cystic fibrosis patients regardless of the severity of disease. In addition, the protein/heparin combining ratio in our study is higher for C F serum samples, when compared to controls, while Pearson and Lubin (15, 16) reported it to be lower. The reason(s) for discrepancies between the two studies cannot be explained by procedural differences since the methods described by Pearson and Lubin were followed exactly.
We have extended these observations by demonstrating that at pH 5.57 the major heparin precipitahle protein in human serum is IgG. The evidence is as follows: (I) a prominent precipitin band appears only in the gamma globulin region after immunoelectrophoresis of DEAE-Sephadex fractions from urea-solubilized heparin-protein precipitates. This band is missing in the supernate. Double immunodiffusion of the precipitate fractions shows reactivity with anti-IgG antiserum but not with anti-IgM, IgA, or lysozyme antisera; (2) SDS-PAGE of the DEAE-Sephadex fractions from solubilized precipitates (especially Peak I) reveals major bands that comigrated with heavy and light chains of IgG; (3) over 50% of the serum protein precipitated by heparin and then eluted from DEAE-Sephadex columns was found by radial immunodiffusion to be IgG; (4) when whole serum is fractionated on Staph A-Sepharose into non-IgG and IgG fractions, 85-89% of the total protein precipitated by heparin resides in the IgG fraction; and (5) furthermore, we have shown that increased amounts of precipitate formed in CF sera are closely correlated with elevated IgG levels.
Different values for the amount of protein in NaOH-solubilized precipitates (Table l) , the amount of protein recovered from DEAE-Sephadex chromatography of urea-solubilized precipitates (Table 5) , and the amount of protein precipitated after Staph Protein A fractionation (Table 6 ), can be attributed to the different methods of protein estimation and standards used in each of these experiments. First, when the Fluram method of protein estimation is used with bovine serum albumin as standard, the protein content of a sample containing predominantly IgG is underestimated by about 60% (unvublished data). Thus. if one corrects the data shown in ~a b l e j for the 60% inderestimate and compares it with the data shown in Table 1 , a 66% recovery is calculated. This figure is roughly comparable with the usual recovery of IgG from DEAE (4). In addition, the measured levels of IgG in urea-treated samples may not be as high as expected because there may have been a loss of antigenically reactive IgG. Recovery data from the DEAE column are not reported because the amounts of urea and Tris required to solubilize the pellets interferes with both the Fluram and Lowry methods of protein estimation. Finally, heparin precipitation of serum fractions may not mimic precipitation from whole serum. However, this experiment did show that approximately one-half of the serum IgGs are capable of interacting with heparin and that other serum proteins are considerably less SO. There are several reports in the literature that the concentrations of IgG are elevated in many patients with cystic fibrosis, particularly in those over the age of 10. Matthews et al. (12) examined 419 patients with cystic fibrosis. They found that, compared with normals, of 178 patients 10-20 years old, 24% had elevated serum levels while of 87 patients over the age of 20, 47% had elevated levels. On the other hand, in patients under the age of 10 only 6.5% had elevated levels, while 22% had low levels. In our study, in patients over 12, over 50% had elevated IgG levels, and only 10% had low levels compared with age-matched controls. In younger patients, this was reversed: 50% had low levels while only 13% had high levels compared with age-matched controls. In our study, protein-heparin precipitates from patients under the age of 12 also showed no differences from normals in the amount of protein or heparin precipitated. This supports our contention that increased levels of precipitable proteins are related to elevated concentrations of serum IgG.
Can the increase in heparin-precipitable protein be largely accounted for by the increase in IgG levels seen in patients with cystic fibrosis? While our studies show a mean increase in IgG levels of 3.2 mg/ml, Weeke et al. (21) report that on average, patients with cystic fibrosis have an increase of 5 mg of IgG per ml of serum and Schwartz (18) reports that the serum levels in older patients are increased by 6.86 mg IgG per ml of serum, which compares favorably with the 6.13 mg of extra protein in precipitates of cystic fibrosis serum (see Table I ). None of the other 17 proteins examined by Weeke et al. showed an increase in CF serum samples that even approached this magnitude, except for alpha2-macroglobulin, which showed an average increase of 1.3 mg. The absence of any precipitin bands in the alpha globulin region on immunoelectrophoresis of the precipitated proteins is a strong indication that this protein was not precipitated to any significant degree. It is unlikely that other serum proteins, alone or in combination, contribute substantially to the heparin precipitation effect in CF serum.
One possible reason for the scatter in the data presented in Table 5 may be differences in the individual immune responses. It is well documented that the humoral response to specific types of antigens (i.e., polysaccharide, protein, etc.) is subclass restricted (17, 23) and that the isoelectric points of the IgG subclasses vary; IgGI, pI 6.8 to < 9, IgG2, pI 6.3-8.4; IgG3, pI 8.0-9.0; IgG4, pI < 6.2 (22) . Thus the concentrations of the various subclasses can vary depending on which antigen has elicited a response. In addition, Shakib et al. (19) have reported that CF patients have altered ratios of serum IgG subclasses. Because of the electrostatic nature of the heparin-protein complex (a), changes in the relative amounts of the four IgG subclasses would be expected to affect the amount of protein and heparin precipitated.
An alternate hypothesis is suggested by Levy, et al. (9) who have demonstrated that all eight heparin-binding myeloma proteins studied had cross-reacting idiotypes not found in 92 nonheparin binding monoclonal IgGs. No other common feature was found, i.e., light chain type, isoelectric point, or subclass. Perhaps serum from CF patients has larger amounts of IgGs with idiotypes similar to those found by Levy, et al. Pearson and Lubin (16) have put forth the hypothesis that "the glycoprotein biosynthetic mechanism in cystic fibrosis is genetically altered and produces glycoproteins of abnormal carbohydrate composition which combine with normal, acid glycosaminoglycans to form insoluble, viscous complexes that hinder normal cellular and subcellular transport mechanisms and metabolic processes." This hypothesis is based on the analysis of the carbohydrate composition of the protein-heparin precipitates, the results of which are as follows: a 27% decrease in sialic acid, a 27% increase in fucose, and a 3 1% decrease in hexose in glycoproteins precipitated from cystic fibrosis serum as compared with controls, although no differences in the carbohydrate composition of whole serum were found (16) . Accordingly we are currently investigating whether the carbohydrate content of IgGs from CF serum is different from that of IgGs from normal serum.
Since we have shown that only one major class of serum proteins is precipitated by heparin, a generalized defect in glycosylation is not suggested by the altered CF serum protein-heparin interactions, although a specific alteration in IgG glycosylation is not ruled out. This conclusion is also supported by the work of Hunt and Summers (6), who showed that G protein of vesicular stomatitis virus is normally glycosylated when grown in CF fibroblasts, and of Margolies (I I), who examined the levels of fucosyland sialytransferases in CF fibroblasts and lymphoid lines and found no alterations in these enzyme activities. We suggest that the previously reported alterations of the carbohydrate content may reflect differences in the IgG subclass distribution in CF (19) .
Our observations also make a generalized alteration in glycoprotein: glycosaminoglycan interaction an unlikely explanation for the heparin effect first described by Pearson and Lubin (16) . However, serum-type glycoproteins are synthesized by a mechanism entirely different from that of mucous-type glycoproteins (5, 20) . Therefore failure to uncover abnormalities of serum glycoproteins does not preclude alterations of mucous glycoprotein synthesis or metabolism in CF.
